Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001437749-22-007349
Filing Date
2022-03-28
Accepted
2022-03-28 14:24:23
Documents
48
Period of Report
2022-01-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q/A bsyn20220131_10qa.htm   iXBRL 10-Q/A 436162
2 EXHIBIT 31.1 ex_350017.htm EX-31.1 11615
3 EXHIBIT 31.2 ex_350018.htm EX-31.2 14012
4 EXHIBIT 32.1 ex_350019.htm EX-32.1 4495
5 EXHIBIT 32.2 ex_350020.htm EX-32.2 4498
  Complete submission text file 0001437749-22-007349.txt   2679482

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA bsyn-20220131.xsd EX-101.SCH 33515
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bsyn-20220131_cal.xml EX-101.CAL 35705
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bsyn-20220131_def.xml EX-101.DEF 197581
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE bsyn-20220131_lab.xml EX-101.LAB 181034
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bsyn-20220131_pre.xml EX-101.PRE 215524
42 EXTRACTED XBRL INSTANCE DOCUMENT bsyn20220131_10qa_htm.xml XML 269267
Mailing Address 55 WEST MONROE STREET STE 1200 CHICAGO IL 60603
Business Address 55 WEST MONROE STREET STE 1200 CHICAGO IL 60603 8479560471
BIOSYNERGY INC (Filer) CIK: 0000715812 (see all company filings)

EIN.: 362880990 | State of Incorp.: IL | Fiscal Year End: 0430
Type: 10-Q/A | Act: 34 | File No.: 000-12459 | Film No.: 22774941
SIC: 3829 Measuring & Controlling Devices, NEC